China CAS NO 6092-54-2 Factory

We've been also focusing on improving upon the stuff management and QC program to make sure that we could hold fantastic gain in the fiercely-competitive enterprise for CAS NO 6092-54-2,6092-54-2,Dabigatran intermediate,Dabigatran advance intermediate,Hexyl Chloroformate, Honesty is our principle, professional operation is our work, service is our goal, and customers' satisfaction is our future!
CAS NO 6092-54-2, Our company absorbs new ideas, strict quality control, a full range of service tracking, and adhere to make high-quality products. Our business aims to "honest and trustworthy, favorable price, customer first", so we won the trust of the majority of customers! If you are interested in our items and services, remember to do not hesitate to contact us!

Hot Products

  • Tegoprazan

    Tegoprazan

    Product Name:Tegoprazan
    Molecular Formula:C20H19F2N3O3
    Molecular Weight;387.38
    CAS Registry Number;942195-55-3
  • 1,3,5-Triazine-2,4,6-(1H,3H,5H)-trithione trisodium salt

    1,3,5-Triazine-2,4,6-(1H,3H,5H)-trithione trisodium salt

    Product Name:1,3,5-Triazine-2,4,6-(1H,3H,5H)-trithione trisodium salt
    Molecular Formula:C3H4N3NaS3
    Molecular Weight:201.26
    CAS Registry Number:17766-26-6
  • SAMARIUM

    SAMARIUM

    Product Name:SAMARIUM
    Molecular Formula:Sm
    Molecular Weight:150.36
    CAS Registry Number:7440-19-9
  • 5-Fluorouracil

    5-Fluorouracil

    Product Name:5-Fluorouracil
    Molecular Formula:C4H3FN2O2
    Molecular Weight:130.08
    CAS Registry Number:51-21-8
  • 3-Formylphenylboronic acid

    3-Formylphenylboronic acid

    Product Name:3-Formylphenylboronic acid
    Molecular Formula:C7H7BO3
    Molecular Weight:149.94
    CAS Registry Number:87199-16-4
  • 2-Cyanobenzyl Bromide

    2-Cyanobenzyl Bromide

    2-Cyanobenzyl Bromide
    CAS NO:22115-41-9
    Usage:Alogliptin Intermediates​

Send Inquiry

X
We use cookies to offer you a better browsing experience, analyze site traffic and personalize content. By using this site, you agree to our use of cookies. Privacy Policy
Reject Accept